Evidence map›Paper›PMID 30547231›Full record

ArticleDiabetologia2019

A novel rare CUBN variant and three additional genes identified in Europeans with and without diabetes: results from an exome-wide association study of albuminuria.

Tarunveer S Ahluwalia, Christina-Alexandra Schulz, Johannes Waage, Tea Skaaby, Niina Sandholm, Natalie van Zuydam, Romain Charmet, Jette Bork-Jensen, Peter Almgren, Betina H Thuesen and 19 more

Open access · hybridAbstract read
In one paragraph

Article in Diabetologia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Observational
  5. Review
  6. Article
  7. Article
  8. Four missense genetic variants inFrontiers in endocrinology · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Variants inAmerican journal of cancer research · 2020
    Article
  17. Article
  18. Frontiers in genetics · 2019
    Article
  19. Editorial: Novel Biomarkers for Type 2 Diabetes.Frontiers in endocrinology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 9 institutions in 6 countries.

Tarunveer S AhluwaliaSteno Diabetes Center Copenhagen, Niels Steensens Vej 2, 2820, Gentofte, Denmark. tarun.veer.singh.ahluwalia@regionh.dk.ORCID 0000-0002-7464-3354
Christina-Alexandra SchulzDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Johannes WaageCopenhagen Prospective Studies on Asthma in Childhood, Gentofte and Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
Tea SkaabyCenter for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Capital Region, Copenhagen, Denmark.
Niina SandholmFolkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Natalie van ZuydamWellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Romain CharmetInserm UMR-S 1166, Sorbonne Universités, UPMC Université Paris, Paris, France.
Jette Bork-JensenNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Peter AlmgrenDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Betina H ThuesenCenter for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Capital Region, Copenhagen, Denmark.
Mathilda BedinParis Descartes University-Sorbonne Paris Cité, Imagine Institute, Paris, France.
Ivan BrandslundDepartment of Clinical Immunology and Biochemistry, Lillebaelt Hospital, Vejle, Denmark.
Cramer K ChristensenDepartment of Internal Medicine and Endocrinology, Lillebaelt Hospital, Vejle, Denmark.
Allan LinnebergCenter for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Capital Region, Copenhagen, Denmark.
Emma AhlqvistDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Per-Henrik GroopFolkhälsan Institute of Genetics, Folkhälsan Research Center, Helsinki, Finland.
Samy HadjadjL'institut du thorax, Department of Endocrinology, CIC 1413 INSERM, CHU Nantes, Nantes, France.
David-Alexandre TregouetInserm UMR-S 1166, Sorbonne Universités, UPMC Université Paris, Paris, France.
Marit E JørgensenSteno Diabetes Center Copenhagen, Niels Steensens Vej 2, 2820, Gentofte, Denmark.
Niels GrarupNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Oluf PedersenNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Matias SimonsParis Descartes University-Sorbonne Paris Cité, Imagine Institute, Paris, France.
Leif GroopDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Marju Orho-MelanderDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Mark I McCarthyWellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Olle MelanderDepartment of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
Peter RossingSteno Diabetes Center Copenhagen, Niels Steensens Vej 2, 2820, Gentofte, Denmark.
Tuomas O KilpeläinenNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Torben HansenNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
University of Copenhagen · DKLund University · SEFrederiksberg Hospital · DKInserm · FRUniversity of Helsinki · FICentre for Human Genetics · GBLillebaelt Hospital · DKUniversité Paris Cité · FRSteno Diabetes Centers · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisIdentifying rare coding variants associated with albuminuria may open new avenues for preventing chronic kidney disease and end-stage renal disease, which are highly prevalent in individuals with diabetes. Efforts to identify genetic susceptibility variants for albuminuria have so far been limited, with the majority of studies focusing on common variants.

methodsWe performed an exome-wide association study to identify coding variants in a two-stage (discovery and replication) approach. Data from 33,985 individuals of European ancestry (15,872 with and 18,113 without diabetes) and 2605 Greenlanders were included.

resultsWe identified a rare (minor allele frequency [MAF]: 0.8%) missense (A1690V) variant in CUBN (rs141640975, β = 0.27, p = 1.3 × 10 CONCLUSIONS/

interpretationThe current study identifies a rare coding variant in the CUBN locus and other potential genes associated with albuminuria in individuals with and without diabetes. These genes have been implicated in renal and cardiovascular dysfunction. The findings provide new insights into the genetic architecture of albuminuria and highlight target genes and pathways for the prevention of diabetes-related kidney disease.

Indexed as

AlbuminuriaAllelesDiabetes MellitusDiabetic NephropathiesGene FrequencyGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansPolymorphism, Single NucleotideReceptors, Cell SurfaceWhite Peopleintrinsic factor-cobalamin receptorReceptors, Cell SurfaceAlbuminuriaDiabetesDKDExome chipGeneticsGenome-wide association studyGWASKidney diseaseRare variantSKATType 2 diabetes

Identifiers

PMID30547231
PMCPMC6323095
OpenAlexW2904074600

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.